Podcasts about alzheimer's research

Philippa interviews Trevor Wood about “The Silent Killer” and reviews Annie Bot by Sierra Greer & Only Big Bum Bum Matters Tomorrow by Damilare KuKu.Link to Trevor's fundraising for Alzheimers Research: https://justgiving.com/page/trevor-wood-1731935935062Trevor recommends:Blood Like Mine by Stuart NevillePaperboy by Callum McSorley A Serpent in the Garden by Howard Linskey Hosted on Acast. See acast.com/privacy for more information.

(***TIMESTAMPS in description below) ~ Louisa Nicola is a Neurophysiologist and Performance Based Coach. She focuses on Alzheimers Research and hosts the Neuro Experience Podcast. LOUISA'S LINKS: Instagram: https://www.instagram.com/louisanicola_/ YouTube: https://youtube.com/@louisanicola?si=BGz-VSmJeDurd1Oe Website: https://www.neuroathletics.com.au/ EPISODE LINKS: - Julian Dorey PODCAST MERCH: https://juliandorey.myshopify.com/ - Support our Show on PATREON: https://www.patreon.com/JulianDorey - Join our DISCORD: https://discord.gg/Ajqn5sN6 JULIAN YT CHANNELS: - SUBSCRIBE to Julian Dorey Clips YT: https://www.youtube.com/@juliandoreyclips - SUBSCRIBE to Julian Dorey Daily YT: https://www.youtube.com/@JulianDoreyDaily - SUBSCRIBE to Best of JDP: https://www.youtube.com/@bestofJDP ***TIMESTAMPS*** 00:00 - Studying Brain Health (Alzheimer's, Dementia, etc.) and Human Performance 10:31 - Most Important Blood Markers & Predicting Long Term Health 21:16 - Breaking Down the Brain & Making Elite Athletes Better 34:13 - How to Preserve Brain Health & Create Lasting Longevity 42:51 - Importance of Supplements & The Most Important Habit that Can Change Your Life 55:53 - How to Improve Sleep & Dangers of Lack of Sleep 01:07:11 - Taking Drugs & Its Impact on Health 01:16:03 - Pharmaceutical Industries Corrupt Nature & Ozempic 01:24:33 - Alzheimers & Tragic Rise & Possible Cure, This Hormone Can Make or Break You 01:36:01 - Inflammation & Beware of Certain Supplement Brands 01:46:51 - Why People Struggle to be Healthy 01:56:33 - Reacting to the Man Who Wants to Live Forever & Exposing Gary Brecka 02:15:09 - Louisa On Career, Having Family & Kids, Social Media Causing Infidelity 02:26:03 - How Divorce Causes Major Health Complications 02:34:31 - Sunlight & Most Important Supplement To Take 02:41:11 - Valuable Accessories & Cancer Research 02:51:29 - Find Louisa CREDITS: - Hosted & Produced by Julian D. Dorey - Intro Editor & Producer: Alessi Allaman: https://www.instagram.com/allaman.docyou/ ~ Get $150 Off The Eight Sleep Pod Pro Mattress / Mattress Cover (USING CODE: “JULIAN DOREY”): https://eight-sleep.ioym.net/trendifier Julian's Instagram: https://www.instagram.com/julianddorey ~ Music via Artlist.io ~ Julian Dorey Podcast Episode 230 - Louisa Nicola

On the Wednesday, Nov. 22 edition of Georgia Today: Georgia is getting a funding boost for Alzheimer's research; Savannah-based aircraft maker, GulfStream, sets a transatlantic flight historic first; and we talk with Georgia-born musician Chan Marshall, better known as Cat Power, about her new Bob Dylan covers album. 

*The information in this podcast is intended for Healthcare Practitioners. Alzheimer's disease is a devasting illness that robs patients of quality and quantity of life and is the leading cause of death in women. Alzheimer's is also the most feared condition in middle to older age adults. This may be in part due to fact, to date, there is little to no evidence that pharmaceutical intervention can slow, let alone reverse, the condition once established. Despite the current pessimistic outlook, there is a growing body of evidence that Alzheimer's can be prevented, slowed, and potentially reversed. Joining the podcast is a juggernaut in Alzheimer's research, Prof Ralph Martins. For over three decades Prof Martins has explored Alzheimer's from all angles – and the future looks promising. In this episode Prof Martins discusses the central role of beta amyloid in Alzheimer's, whilst touching upon some concerns of its clinical utility. Further, Prof Martins reveals some emerging biomarkers that may be a game changer in the near future. Prof Martin then describes powerful, yet not widely appreciated risk factors, namely hearing loss and poor sleep. The conversation also explores the role of APOE in Alzheimer's and findings from his research on dietary factors linked to neuroprotection. Despite the size of the problem, the details in the podcast and Prof Martins' energy and passion should leave listeners with confidence positive change is on the horizon. Professor Ralph Martins is the Foundation Chair in Aging and Alzheimer's Disease at Edith Cowan University. His collaborative seminal research involved isolating and characterising beta-amyloid and its precursor, the amyloid precursor protein (APP), which are now recognised as central to the pathogenesis of Alzheimer's disease. He was the first to propose and demonstrate that the Alzheimer brain was under oxidative stress, which is now widely recognized by the Alzheimer research community. Ralph's current research interests are focused on understanding the mechanisms and factor(s) leading to the abnormal release and deposition of βA4 in Alzheimer's disease. Useful Links: Australian Alzheimer's research foundation https://alzheimers.com.au/ Lions Alzheimer's Foundation https://lionsalzheimersfoundation.com.au/ The Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) https://aibl.csiro.au/

In this episode, Tommy and Andrew mostly talk about Alzheimers Disease, from cause to potential prevention. Sprinkled into the conversation are thoughts on scientific research being corrupted, if it's better to be alive now than 100 years ago, and why the current state of Hospitals falls on the shoulders of the public. Purchase Tommy's MetFlex-Rx Diet Book: https://amzn.to/2ZUeMBm Purchase Tommy's Behaviour Change Book on Audible: https://amzn.to/3IjqEOJ Dr.Appleton's Website: https://andrewappletonmd.ca/

Stephen G. Post, Ph.D., is internationally recognized for his work with deeply forgetful people, their families and allied organizations. His book The Moral Challenge of Alzheimer's Disease: Ethical Issues from Diagnosis to Dying (Johns Hopkins University Press, 2000) was designated a “medical classic of the century” by the British Medical Journal. His research on the dynamics of compassionate care in the lives of persons with dementia and their caregivers resulted in his being elected a member of the Medical and Scientific Advisory Board of Alzheimer's Disease International. He is also one of only several recipients of the Alzheimer's Association national distinguished service award “in recognition of personal and professional outreach to the Alzheimer's Association Chapters on ethics issues important to people with Alzheimer's and their families.”Website stephengpost.com unlimitedloveinstitute.orgBooksDignity for Deeply Forgetful People God and Love on Route 80: The Hidden Mystery of Human Connectedness Why Good Things Happen to Good People

We start the show and the new month of December, with a report on Karing For Kids. Karing For Kids is a charity founded by Hucks Market, a convenience store chain in the midwest. Adam was honored to emcee the recent Karing For Kids golf outing and banquet. Other segments include; A Sock Drive by […]

Allocating corporate funds to causes can be critical for many nonprofit organizations. This week Samantha Sayward explains how an organization's investment in nonprofit research can impact the financial future of any organization. Listen in as Laura and Samantha discuss how to share the impact of participating in a solution, being accountable for your actions as a leader, and how the Alzheimer's Association navigates the complex relationships between stakeholders   Here are a few things you'll learn during this conversation: The difference between transformational and transactional relationships How to listen to and receive critical feedback Why leaders should be open and transparent when making decisions How to be respected as a person and not as a title Navigating the transition from military to corporate leadership   During the 24-Hour Influence Challenge, Samantha encourages you to be open to feedback by asking your team three questions: what would you like me to do more of? What would you like me to do less of? What would you like me to do differently?   Samantha Sayward is the Senior Walk Director for the Alzheimer's Association Delaware Valley Chapter. Samantha has worked in the non-profit industry for over 6 years- with her primary role being in development. Samantha became aware of the Alzheimer's Association when her grandmother was diagnosed with Dementia in 2016. She participated in the Walk to End Alzheimer's - the Alzheimer's Association flagship event and has been walking ever since. Prior to her work at the Alzheimer's Association and other non-profits, Samantha served in the U.S. Navy for 5 1/2 years as a Hospital Corpsman (CORE-MAN). Samantha also serves on the board for USA Dodgeball and owns her own sports league in Philadelphia.   You can learn more about the Walk to End Alzheimer's at www.als.org   To learn more about Dr. Laura Sicola and how mastering influence can impact your success go to https://www.speakingtoinfluence.com/quickstart and download the quick start guide for mastering the three C's of influence.   You can connect with Laura in the following ways:   LinkedIn: https://www.linkedin.com/in/drlaurasicola LinkedIn Business Page: https://www.linkedin.com/company/vocal-impact-productions/ YouTube: https://www.youtube.com/c/VocalImpactProductions Facebook: Vocal Impact Productions Twitter: @Laura Sicola  Instagram: @VocalImpactProductionsSee omnystudio.com/listener for privacy information.

John Robertson is an award-winning editorial photographer working for national and international newspapers and magazines. He supplies photos on a regular basis to The Guardian ,The Telegraph, The Sydney Morning Herald and many other newspapers since 1987. He also shoots commercial, PR, advertising, TV and film stills, stock and corporate photography. John is an Ambassador for Manfrotto, who he regularly writes articles and photographs for. He has worked with the photographic equipment firms Sigma and Interfit and continues to supply both video and photos for national charities, including Alzheimers Research and Cliksargent.

Problem gambling - would it help to ban the use of credit cards online or at the bookies ...Miss Cork Zoe Hendrick on why Alzheimers awareness is so important to her..If your friend is sick..how even a text or a quick call can mean the world & there's lots more See acast.com/privacy for privacy and opt-out information.

Dr Fiona Calvert narrates this blog written by Molly Massetti written for NIHR Dementia Researcher. Fiona and Molly discuss the new ARUK Fellowship Funding Call - with guidance for potential applicants Find the original text, and narration here on our website. https://www.dementiaresearcher.nihr.ac.uk/alzheimers-research-uks-call-for-early-career-researchers/  If you would like to write for us, or join out team of regular contributors, drop us a line - dementiaresearcher@nihr.ac.uk

Kitty chats with Karen Penny about the final day of walking around the Isle of Wight and now that she is on the mainland - where she is walking to next.

Every day this week, Vectis Radio has been chatting with Karen Penny who is right now completing the Isle of Wight leg of her epic journey around Britain and Ireland - fundraising for Alzheimers Research UK.You can keep up to date with Karen's journey by watching her social media and also listen to her chats with Kitty every day on the mid morning show this week (and the lunchtime show on Sunday).Karen would love you to say Hello as she walks round our wonderful Isle of Wight it is Karen's penultimate day on the island todayListen in , you don't want to miss this

Every day this week, Vectis Radio will be chatting with Karen Penny who is right now completing the Isle of Wight leg of her epic journey around Britain and Ireland - fundraising for Alzheimers Research UK.You can keep up to date with Karen's journey by watching her social media and also listen to her chats with Kitty every day on the mid morning show this week (and the lunchtime show on Sunday).Karen would love you to say Hello as she walks round our wonderful Isle of Wight Listen in , you don't want to miss this

Every day this week, Vectis Radio will be chatting with Karen Penny who is right now completing the Isle of Wight leg of her epic journey around Britain and Ireland - fundraising for Alzheimers Research UK.You can keep up to date with Karen's journey by watching her social media and also listen to her chats with Kitty every day on the mid morning show this week (and the lunchtime show on Sunday).Karen would love you to say Hello as she walks round our wonderful Isle of Wight Listen in , you don't want to miss this

Every day this week, Vectis Radio will be chatting with Karen Penny who is right now completing the Isle of Wight leg of her epic journey around Britain and Ireland - fundraising for Alzheimers Research UK.You can keep up to date with Karen's journey by watching her social media and also listen to her chats with Kitty every day on the mid morning show this week (and the lunchtime show on Sunday).Karen would love you to say Hello as she walks round our wonderful Isle of Wight Listen in , you don't want to miss this#alzheimersresearchuk

Every day this week, Vectis Radio will be chatting with Karen Penny who is right now completing the Isle of Wight leg of her epic journey around Britain and Ireland - fundraising for Alzheimers Research UK.You can keep up to date with Karen's journey by watching her social media and also listen to her chats with Kitty every day on the mid morning show this week (and the lunchtime show on Sunday).Karen would love you to say Hello as she walks round our wonderful Isle of Wight Listen in , you don't want to miss this

Karen Penny is raising funds for Alzheimers Research UK currently by walking around the UK and its islands.Kitty chats with Karen about her imminent visit to the Isle of Wight to complete this leg of her epic journey.Vectis Radio will be following Karen around the island as she commences her walk on Tuesday 13 April 2021.Listen in daily to Vectis Radio , on Vectis social media pages and our website of course , to find out where Karen is and how she is doing on her fantastic walk.

Older Victorians who are worried about their memory are needed for an ambitious research project to treat Alzheimer's disease before symptoms appear. The former Mount Scopus principal spruiked as a star reference for fake teacher Neil Lennie said he had no idea he was used to defend the fraudster. Family of two brothers accused of plotting a terror attack in Melbourne say it's all a misunderstanding. There are more than 44,700 jobs crying out for workers in Victoria right now, and experts say this is the best time to apply. If you would like to read more on that story today, you can take out a subscription to the Herald Sun at heraldsun.com.au or download the app at your app store. See omnystudio.com/listener for privacy information.

Alzheimer's disease affects more than 6 million Americans and a disproportionate number are Black. NPR science correspondent Jon Hamilton explains why Black Americans may be at higher risk, and how diversifying Alzheimer's research could lead to a better understanding of the disease in Black Americans, and new treatments for everyone. Email the show at shortwave@npr.org.

Our highlight story is on a 70-year-old man from England who rowed across the Atlantic to raise money Alzheimer's. Other stories include sea foam that essentially blanketed a whole town in Ireland, allegations that Amazon pushed for the change in traffic lights to derail unionization and  news that scientists have found a way to exchange messages with people who are dreaming.Visit the blog (https://taplink.cc/tunukamedia) for pictures and references. © 2021 TunukaMedia  

Dr. Sid O'Bryant, Executive Director of UNT Health Science Center's Institute for Translational Research, is a global leader in better understanding health disparities in brain aging. After watching his grandmother suffer through Alzeheimer's Disease, Dr. O'Bryant – a trained neuropsychologist – taught himself blood science and developed a test to detect the disease. Today, behind more than $60 million in research investments, he leads the world's largest study on better understanding why more Mexican Americans and African Americans, proportionately, suffer from Alzheimer's than their white counterparts.

Rhea and Thelonious discuss an article in The Daily featuring the discovery of abnormal protein structures found in the brains of Alzheimers patients. They also talk about a possible new diagnostic test that could help doctors understand the disease better.

Rhea and Thelonious discuss an article in The Daily featuring the discovery of abnormal protein structures found in the brains of Alzheimers patients. They also talk about a possible new diagnostic test that could help doctors understand the disease better.

We're devoting this episode to the news coming out of the just-concluded J.P. Morgan Healthcare Conference, the drug industry's largest annual meeting. First, we'll dissect Eli Lilly's surprising data on a new Alzheimer's disease treatment and dig into its implications for the field. Then, we discuss whether there's a bubble inflating in the genome editing world, debate who will run the FDA under a President Biden, and consider the legacy of Moncef Slaoui, the outgoing leader of Operation Warp Speed.

Alzheimer's can be considered a "women's disease" because two-thirds of new patients are women. It's also a disease whose victims have been particularly hard-hit during Covid. In 10 Days of Giving Back, we showcase the Women in Alzheimer's Research Fund at UCSF, which puts a "women's lens" on research and early detection. Learn more at https://givingtogether.ucsf.edu/fundraiser/2024067. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Lori La Bey talks with Dr. C. J. Barnum the V.P. and head of Neuroscience at INmune Bio.  They focus on activating the immune system to fight Alzheimer’s disease. Dr. Maxime Descoteaux, is a world-renowned expert in diffusion MRI and medical imaging.  He is the Founder & CSO of Imeka, which offers a noninvasive technology to help understand neuroinflammation in white matter. The trio will cover a lot of ground discussing the science, noninvasive technology and trials they are working on. Contact Our Guests: INmune Bio Contact for David Moss     Email     Website     Phone:  (858) 964-3720    LinkedIn     Imeka Contact for Dr. Maxime Descoteaux      Email    Website     LinkedIn   Contact Lori La Bey or visit Alzheimer’s Speaks  

Lisa's guest, today on Tech Transfer IP, is Travis Cook. Travis is the Associate Director of Technology Development and Licensing at Oregon Health and Science University (OHSU). He is a cross-functional international business development professional with experience managing, negotiating, and closing early, late, and commercial-stage definitive agreements. Travis is also co-inventor on seven patent applications and a co-author of several peer-reviewed publications, including a case study in the management textbook, Building a Case for Biotechnology. Listen, as Travis shares how he ended up at OHSU, what prompted him to write about Myogen, Inc and how he is using the chapter he co-wrote as a teaching tool. He discusses OHSU and many research centers and institutes that are included under the OHSU umbrella. Travis speaks about how his office is structured, the role each department has, and the benefits of having an in-house patent group. He also speaks on how many inventions are disclosed to his office each year, how many they file on, how many they convert, and the copyrights they file on. Listen as he discusses OHSU's corporate partners, how they structure their deals, and what they are working on together. Travis shares some of his office's biggest success stories, how many startups they have, and his three biggest challenges. Travis believes that credentialing is important because it shows a willingness to expand knowledge, but it's not a requirement of employment for his office. We finish the conversation with the three wishes Travis would want for his office if he had a genie in a bottle. This is a great conversation showing how important research is to tech transfer and the amazing things that can be realized with the right minds in place. In This Episode: [01:49] Welcome to the show, Travis! [02:10] Travis shares his background, which led him to Tech Transfer and how he ended up at OHSU. [05:03] He speaks about gaining the master's degree that UCSD offered. [07:07] Travis shares moving to Portland to continue his Business Degree. [11:59] Travis discusses the chapter in his book he co-wrote with Mark Ahn and why they wrote about Myogen, Inc. [15:07] He speaks about the teaching tool that chapter has been. [17:59] Travis shares more about OHSU and many research centers and institutes that are included. [20:59] He speaks about managing an Alzheimer's asset that is progressing in the research facilities. [21:56] Travis discusses how his office is structured and what his team manages. [24:48] Travis is excited that they have a patent group that allows them to place more bets. [26:58] He speaks about his operations team and what they are responsible for. [29:32] Travis shares how many inventions are disclosed by his office per year, and they file on about a third of them per year and convert about 42 applications a year. [30:47] What do your active licenses and revenue numbers look like per year? [32:00] Travis speaks about what his office files copyrights on. [33:16] Travis shares his experience with litigations and whether they have any recent patent litigations. [35:10] Travis discusses their corporate partners and how the deals are structured. [37:42] Travis speaks about one of their major corporate partners and what they are doing together. [42:15] What have you learned over your career with license transactions and or partners, and what would you have done differently? [45:16] Travis talks about how he wants his license agreements to be so good that they don't need to be restructured. [49:35] Travis discusses some of his office's biggest success stories that have had the biggest effects. [52:45] He talks about three of OHSU's remarkable startups. [55:32] What would you say are your two biggest challenges? [58:43] Travis speaks about the programs they have to support women inventors and entrepreneurs. [1:01:55] Travis discusses the organizations they are involved with, like AUTM and others. [1:03:38] Travis thinks credentialing shows that people are willing to expand their knowledge base. [1:05:02] Travis speaks about three things he would want for his office if he had three wishes. [1:06:07] Thank you so much for being on the show! Find Travis: Travis Cook LinkedIn  

Have you ever wanted to know more about Alzheimer's disease? In this episode, Dr. Chris Link, Associate Professor at the University of Colorado Boulder, talks to us about his research working to understand brain diseases like Alzheimer's. He answers questions about developments that have been made in the field of Alzheimer's research and discusses how worms and mice are used to better understand Alzheimer's. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app

Learn what researchers found when they tried to build the perfect profanity, then learn how playing an online game called Stall Catchers can help scientists speed up Alzheimer’s research. Then, test your knowledge with Curiosity Challenge trivia questions. A new study tried to build the perfect swear word by Kelsey Donk Neuroskeptic. (2020, March 31). Building the Perfect Profanity. Discover Magazine; Discover Magazine. https://www.discovermagazine.com/mind/building-the-perfect-profanity  Reilly, J., Kelly, A., Zuckerman, B. M., Twigg, P. P., Wells, M., Jobson, K. R., & Flurie, M. (2020). Building the perfect curse word: A psycholinguistic investigation of the form and meaning of taboo words. Psychonomic Bulletin & Review, 27(1), 139–148. https://doi.org/10.3758/s13423-019-01685-8  Thousands of volunteers are speeding up Alzheimer's research by playing an online game by Steffie Drucker Join a global game that’s trying to cure Alzheimer’s. (2019). Stall Catchers. https://stallcatchers.com/ Cavalier, D. (2020, April 9). How Thousands of People are Helping Find a Treatment for Alzheimer’s Disease. Discover Magazine; Discover Magazine. https://www.discovermagazine.com/mind/how-thousands-of-people-are-helping-find-a-treatment-for-alzheimers-disease  Alzheimer’s Statistics. (2019). Alzheimers.net. https://www.alzheimers.net/resources/alzheimers-statistics/  Brain blood flow finding gives hope for Alzheimer’s therapy | Cornell Chronicle. (2019). Cornell Chronicle. https://news.cornell.edu/stories/2019/02/brain-blood-flow-finding-gives-hope-alzheimers-therapy  Curiosity Challenge episodes: Why Stress Makes You Eat Differently, Humpback Whales Hunt with Bubble Nets, and the Surprising Genetic Reason Females Outlive Males https://curiositydaily.com/why-stress-makes-you-eat-differently-humpback-whales-hunt-with-bubble-nets-and-the-surprising-genetic-reason-females-outlive-males/ Astronauts Grew Lettuce in Space, Why Smelling a Dirty Shirt Can Help You Sleep, and Early Animals That Acted Like an Ancient Internet https://curiositydaily.com/astronauts-grew-lettuce-in-space-why-smelling-a-dirty-shirt-can-help-you-sleep-and-early-animals-that-acted-like-an-ancient-internet/  Using Lava Lamps to Generate Randomness (w/ Matt Parker), How Ritalin Makes You Focus, and What Bacteria Beneath the Sea Floor Means for Life on Mars https://curiositydaily.com/using-lava-lamps-to-generate-randomness-w-matt-parker-how-ritalin-makes-you-focus-and-what-bacteria-beneath-the-sea-floor-means-for-life-on-mars/ Subscribe to Curiosity Daily to learn something new every day with Cody Gough and Ashley Hamer. You can also listen to our podcast as part of your Alexa Flash Briefing; Amazon smart speakers users, click/tap “enable” here: https://www.amazon.com/Curiosity-com-Curiosity-Daily-from/dp/B07CP17DJY

Steven DeKosky, MD discusses whether supplements contribute to brain health. He will describe the difference between rules that apply to FDA approved drugs and supplements advertised to provide health benefits or support good health, that is not FDA approved. He will recognize the reasons why such differences in regulations exist and the difficulties of treating brain disorders while providing healthy nutrition to the brain.

Dr. Ernesto J. Fernandez, DOM, AP, LMHC is a Doctor of Oriental Medicine, an Acupuncture Physician, and a Licensed Mental Health Counselor. Dr. Fernandez began his career in the healing arts in 1984. His interest in this field stemmed from seeking to heal from Chronic Pain and a Mood Disorder from multiple injuries and concussions as a high school wrestler.The author of “The Healer's Journey” and numerous articles, Dr. Fernandez is a popular lecturer, a professional speaker and healthcare consultant and has traveled internationally teaching clinical intensives on cutting-edge Body Mind therapies and techniques. Dr. Fernandez specializes in integrating Functional Medicine, Clinical Nutrition, Energy Medicine, Functional Neurology, Medical Qi Gong, Body Mind and Manual therapies for the recovery and reversal of Traumatic Stress Disorders, Chronic Pain Syndromes, Chronic Degenerative Diseases, Memory Impairment and Dementia. He has additional training and certifications in The Bredesen Protocol for Reversing Mild Cognitive Impairment and Dementia, as well as, the Alzheimer's Research and Prevent Foundation’s Brain Longevity Program.

Dr. Ernesto J. Fernandez, DOM, AP, LMHC is a Doctor of Oriental Medicine, an Acupuncture Physician, and a Licensed Mental Health Counselor. Dr. Fernandez began his career in the healing arts in 1984. His interest in this field stemmed from seeking to heal from Chronic Pain and a Mood Disorder from multiple injuries and concussions as a high school wrestler. The author of “The Healer's Journey” and numerous articles, Dr. Fernandez is a popular lecturer, a professional speaker and healthcare consultant and has traveled internationally teaching clinical intensives on cutting-edge Body Mind therapies and techniques. Dr. Fernandez specializes in integrating Functional Medicine, Clinical Nutrition, Energy Medicine, Functional Neurology, Medical Qi Gong, Body Mind and Manual therapies for the recovery and reversal of Traumatic Stress Disorders, Chronic Pain Syndromes, Chronic Degenerative Diseases, Memory Impairment and Dementia. He has additional training and certifications in The Bredesen Protocol for Reversing Mild Cognitive Impairment and Dementia, as well as, the Alzheimer's Research and Prevent Foundation’s Brain Longevity Program.

Dr. Jenny Hsieh is Professor and Semmes Foundation Endowed Chair in Cell Biology and Director of the UTSA Brain Health Consortium. She has a Ph.D. in Biology from Johns Hopkins University. She runs the Hsieh laboratory, a neural stem cell biology laboratory that focuses on 4 major areas: (1) epilepsy-in-a-dish, (2) 3D cerebral organoids, (3) patient recruitment, and (4) mechanisms of adult neurogenesis.

Difficulty sleeping affects many people with Alzheimer's: sleeping longer than usual, trouble falling asleep or staying asleep, or sleeping during the day and being awake at night. For those who do not have Alzheimer's, regularly getting inadequate sleep can increase your risk for the disease.What does research tell us about the link between insomnia and Alzheimer's? And are there steps we can take to help manage the risk created by poor sleep?Host Meryl Comer speaks with two experts on these questions: David Holtzman, MD, of Washington University in St. Louis has led studies linking sleep disorders to greater amyloid-beta and tau accumulation in the brain and thus to an increased risk of developing Alzheimer's.Kristine Yaffe, MD, of the University of California, San Francisco, is an expert on populations studies as well as sleep and Alzheimer’s disease.Support the show (https://www.usagainstalzheimers.org/ways-donate)

On this episode of the Senior Summit Podcast, Maria is joined by Danny Niederberger, a Republican candidate for Indiana's 5th Congressional District. Candidate Niederberger discusses his stances on elder issues such as Alzheimer's research, elder abuse, and much more! Make sure to share, like, and follow for more episodes! Learn more about his campaign at: https://dannyniederberger.com/

U.S. Representative Tom Cole joins Chris Casteel to talk about the impeachment hearings, government funding, Alzheimer’s research and buffalo.

Alzheimer's Association Desert Southwest Chapter- Where are we with Alzheimer's Research?

Fawaz just completed 30 marathons in 30 days to raise money and awareness for Alzheimer's research UK. He is on the podcast to talk about his journey, the mental struggles & the exciting conclusion. Click on the link to find Fawaz on twitter If you would like to visit our website go to www.everydayrunninglegends.com  If you would like to follow us on twitter go to https://twitter.com/BrodieSharpe  To follow us on insta go to https://www.instagram.com/brodie.sharpe/  We also have our own facebook group to interact with past guests and input for future episode. Click on https://www.facebook.com/groups/247962752500993/ 

Are we thinking about Alzheimer’s the wrong way? Best-selling author Dr. Mark Hyman believes we should shift from seeking a single disease path or drug—to a more dynamic framework that considers the many factors that may contribute to Alzheimer’s and then tailoring therapy to the individual. In this Alzheimer’s Talks, host Meryl Comer speaks with Dr. Hyman, of the UltraWellness Center and Cleveland Clinic, about his field (Functional Medicine) and its innovative approaches to Alzheimer’s and dementia. They also discuss a new report, from our ResearchersAgainstAlzheimer’s network, analyzing the science behind lifestyle changes that seem to delay, slow or reduce risk for Alzheimer’s--and take lots of listener questions. Support the show (https://www.usagainstalzheimers.org/ways-donate)

Fawaz Ghali joined Mick in the studio to talk about the amazing project he is doing to raise money for @AlzResearchUK. In August, 2019, in his late Fathers memory and to support Alzheimer's Research, Fawaz is planning to run 30 marathons in 30 days starting on 11th August and finishing on the 9th of September , meaning a marathon a day. You can follow Fawaz's story on his social media @FawazGhali. And donate on his Just Giving page: https://www.justgiving.com/fundraising/fawaz30marathons30days Originally broadcast 22nd August 2019. Follow @MrMickCoyle & @FawazGhali. Produced by Hannah Farrell.

Current treatments for Alzheimer's disease have only minimal and temporary benefits. While the search for more effective Alzheimer’s treatments has seen many disappointments in recent years, the pipeline of drugs in development is far from empty.ResearchersAgainstAlzheimer’s released its 2019 state-of-the pipeline report, and the findings give cause for optimism. A broader range of ideas is being considered to fight the disease, including three new pathways to attack Alzheimer’s that have emerged in the past year alone. In addition, drugs that target amyloid – historically one of the most popular targets of potential Alzheimer’s drugs – have increased 30% since 2017, showing continued interest in the amyloid pathway. And, researchers believe an effective Alzheimer’s treatment may lie in a “cocktail”—a combination of drugs that target various pathways to treat the disease. Finally, the first wave of Alzheimer's prevention trials is well underway - with results available in coming years.Alzheimer's Talks host Meryl Comer speaks with one of the nation’s leading Alzheimer’s disease researchers, Dr. R. Scott Turner, director of the Georgetown University Memory Disorders Program, about the current Alzheimer's drug pipeline and related questions of diagnosis and prevention methods.Support the show (https://www.usagainstalzheimers.org/ways-donate)

This week, Alzheimer's Disease goes under the microscope: What is it? Why do people get it, and can we cure it? Plus in the news, why the planet needs more trees, a breakthrough in storing computer data, and the science of a good excuse! Like this podcast? Please help us by supporting the Naked Scientists

Dr. Kore Kai Liow, who founded Hawaii Pacific Neuroscience, talks with Island Conversations host Sherry Bracken about Alzheimers--more about the medical aspects--and about clinical trials here in the state involving people at risk for Alzheimers, including those from Hawaii's Big Island and other neighbor islands. Air date:  July 7, 2019

Dr. Rodney Guttman, Professor of Biology in the Hal Marcus College of Science and Engineering at The University of West Florida, joins us to discuss new developments in Alzheimer’s Research and the steps we can take to help keep our brains healthy.

Dr. Maria Carrillo, Chief Science Officer at the Alzheimer’s Association. Dr. Carillo is one of the world’s leading experts in Alzheimer’s and related dementia research. Under Dr. Carrillo’s leadership, the Alzheimer’s Association is the world’s largest nonprofit funder of Alzheimer’s research and an internationally recognized pioneer in convening the dementia science community to accelerate the field.

We talk to Katja Brose, neuroscientist and Science Program Officer at the Chan Zuckerberg Science Initiative about the latest, best prospects in neurodegenerative disease treatment.

Lori La Bey talks with Pietro Michelucci a cognitive scientist who directs the Human Computation Institute, which is a research center that develops crowd-powered systems to tackle big societal problems like Alzheimer's disease. Pietro coordinated the Stall Catchers Megathon last month to accelerate Alzheimer’s disease research, which allows anyone to help analyze real Alzheimer's data. Today they will discuss the outcomes from the April Megathon, what they learned from that set of data analyzed and where they go from here. PlayStallCatchers.comanytime. Great Article on Stall Catchers Emailinfo@eyesonalz.com with any questions any time Find Additional Resources at Alzheimer's Speaks

Thomas Wisniewski, MD

Leader: Carl Cohen, MD, Carla Boutin-Foster, MD, Marilyn Fraser, MD, Deborah Gustafson, MD, Howear Crystal, MD

Mary Mittelman, DrPH

Leader: Carl Cohen, MD, Carla Boutin-Foster, MD, Marilyn Fraser, MD, Deborah Gustafson, MD, Howear Crystal, MD

Anafidelia Tavares, MD, MPH

Michael Reinhardt, MD

Mary Mittelman, DrPH

Thomas Wisniewski, MD

Michael Reinhardt, MD

Anafidelia Tavares, MD, MPH

Lori La Bey talks with researchers heading up a Megathon to push Alzheimer's Research ahead one year by getting 100,000 people to play the game "Stall Catchers" for one hour.  The Megathon will occur April13th, 2019 at 1:30pm - 3:30pm ET. Listen in and learn about the fascinating work of Chris Schaffer and Nozomi Nishimura who are Associate Professors at the Meinig School of Bio-medical Engineering at Cornell University, and run the Schaffer-Nishimura Lab. Their lab develops new imaging techniques that allow them to see blood flow in the brains of mice, which led to the discovery of stalls. By another unanticipated discovery, they were able to show that by removing these stalls improved memory and reduced other Alzheimer's symptoms in mice. Pietro Michelucci is a cognitive scientist who directs the Human Computation Institute, which is the research center that developed crowd-powered systems to tackle big societal problems like Alzheimer's. In 2015, he launched the EyesOnALZ citizen science project to accelerate Alzheimer’s disease research, with an online game called Stall Catchers, that allows anyone to participate directly in the search for a treatment. Also joining us are Judy Johanson who was a care partner for her husband and Harry Urban, living with dementia. Read Full Press Release PlayStallCatchers.comanytime. Find Additional Resources at Alzheimer's Speaks

In this episode, I describe one of my favorite meditations — kirtan kriya. This meditation is not only one of the foundational practices in kundalini yoga, it is also the recommended technique by the Alzheimer's Research and Prevention Foundation. It has been scientifically proven to change the structure of the brain, leading to better brain health. Join me as I describe the benefits and walk you through this beautiful meditation practice. Learn more about Kirtan Kriya on the 3HO website and at the Alzheimer's Research and Prevention Foundation. To support the show, please tell a friend, share on social media, and rate/review on your favorite podcast platform. Find more information on www.thirdeyescience.comMusic by www.bensound.com

[The charity is holding it's annual meeting at the Conference Centre in Harrogate with over 450 leading researchers sharing their latest findings.](https://www.strayfm.com/news/health/2830883/harrogate-hosts-global-dementia-conference/)

We wanted to follow up our last episode on the basics of AD treatment with a "where's the puck going" episode with Dr. Aing Li Lin.  Here, we talk about some things she see's as the next level in diagnosis and treatment of this disease.  

RESEARCHERS HAVE UNCOVERED A PART OF THE EXPLANATION FOR WHY THIS ONE TYPE OF HEALTH ISSUE IS LINKED WITH INCREASED TAU PROTEIN LEVELS IN THE BRAIN LINKED TO ALZHEIMERS. CRITICAL NEW WAYS TO AVOID THE TERRIBLE CONSEQUENCES OF ALZHEIMERS DISEASE. TUNE IN.

Do you have just 12 minutes a day to dedicate to your brain? Know anyone starting to have memory loss who might spend 12 minutes a day? New research on an ancient practice called the Kirtan, Kriya or KK from the Alzheimer's Research and Prevention Foundation in Tucson, Arizona had been published. This a tool you can learn quickly and use daily for your health. Dr. Kahn has been using it for years. Teach it to others. Learn more on this edition of Heart Doc VIP on Empower Radio.

Research has linked head injury and a variety of mental health conditions to a higher risk of Alzheimer’s and dementia. Given veterans’ exposure to traumatic brain injury, PTSD, blast-induced neurotrauma, successive concussion syndrome, and depression, what do they and their families need to know about Alzheimer’s? And what’s currently done to help the nearly 50% of our veterans age 65 or older, who face an even greater risk of Alzheimer’s?With Veterans Day approaching, two experts from the U.S. Department of Veterans Affairs (VA) joined us. Dr. Tom Edes oversees Geriatrics & Extended Care Operations, for VA Clinical Operations. Dr. Alex Chiu leads VA’s portfolio of Alzheimer’s disease research.Dr. Edes discussed how VA is addressing this looming crisis and some of the resources that VA offers to veterans who are facing this disease. Dr. Chiu shared on overview of current and recent VA research into Alzheimer’s as it affects our nation’s veterans. This health crisis is affecting our veterans at an alarming rate, when they have already given so much in service to our country. Support the show (https://www.usagainstalzheimers.org/ways-donate)

Prof. Claude Wischik, of Tau Rx Therapeutics and the University of Aberdeen, describes his 30-year quest to study the role of tau in Alzheimer's and to pursue a treatment to fight the tau tangles that form in the brain in Alzheimer's. How has tau research evolved, and what is the current state of knowledge?Support the show (https://www.usagainstalzheimers.org/ways-donate)

Two renowned Alzheimer's researchers and a clinical trial participant share their top takeaways from the Alzheimer’s Association International Conference, the largest gathering of Alzheimer’s researchers from across the world. They shared insights related to Alzheimer’s disparities impacting communities of color and about patient-centered research. Support the show (https://www.usagainstalzheimers.org/ways-donate)

Claire E. Day, Chief Program Officer, Alzheimer's Association Northern California and Northern Nevada Chapter, joins us to discuss the latest in Alzheimer's research. --- Send in a voice message: https://anchor.fm/caring-conversations/message

Is there anything each of us can do to protect our cognitive function or even reduce our risk of Alzheimer’s? Just as we have found ways to reduce heart disease risk, researchers increasingly think there may be steps we can take to ward off Alzheimer’s. Globally renowned researcher Dr. Laura Baker of the Wake Forest School of Medicine discusses the U.S. POINTER study, which she is leading and which is enrolling participants now. This exciting study will test whether changing one’s lifestyle involving physical exercise, diet and intellectual and social stimulation can protect cognitive function in adults 60-79 years old who may be at increased risk of cognitive decline and dementia. The U.S. POINTER study is part of a global collaboration that will build on similar studies in Finland (the FINGER study) and elsewhere and that will include other countries in the near future.Support the show (https://www.usagainstalzheimers.org/ways-donate)

Does research into new Alzheimer's treatments reflect what matters most to those living with the disease and their care partners? When new drugs become available, will they address the symptoms and make the changes in people’s lives that are most important to them? Researcher Brett Hauber of RTI Health Solutions discusses the new What Matters Most Study. UsAgainstAlzheimer’s and its partners are launching this study to learn what matters most to those living with Alzheimer’s, so that insights from those with Alzheimer's and their care partners are considered as drugs are developed, approved, and brought into patient’s lives.Support the show (https://www.usagainstalzheimers.org/ways-donate)

Amy is part of a Cambridge University study to find a treatment for Alzheimer's. Read more >> https://ift.tt/2wjn8mp

Principal investigator, r. Robert Sutherland, talks about a new frontier of research into the origins of Alzheimers disease.

Are depression and anxiety risk factors for Alzheimer’s – or is it the other way around? The better we understand the link between psychiatric symptoms and dementia, the more we can improve brain health. Harvard/Massachusetts General's Dr. Jennifer Gatchel discusses her groundbreaking research into the links between depression, anxiety and Alzheimer’s. Support the show (https://www.usagainstalzheimers.org/ways-donate)

How can texting help fight Alzheimer's? Brainworks, led by Dr. Karen Lincoln, is the first study of its kind, using daily, tailored texting to boost knowledge about Alzheimer’s and to change views toward clinical trials among African-Americans. Stephanie Monroe, Executive Director, AfricanAmericansAgainstAlzheimer's, talks with Karen Lincoln, PhD, Director, Hartford Center of Excellence in Geriatric Social Work; Associate Professor, School of Social Work; and Founder, Advocates for African American Elders, University of Southern California.Support the show (https://www.usagainstalzheimers.org/ways-donate)

How can I find out about Alzheimer's clinical trials and whether I qualify? What is it like to be in a trial? Hear from a Harvard Alzheimer's researcher, two clinical trial participants, and a decision-tool developer on these and other questions.Support the show (https://www.usagainstalzheimers.org/ways-donate)

University of Alberta chemistry researcher, Matthew Macauley, speaks about new findings on a protein call CD33 which, it's believed, has an impact on the development of alzheimers disease.

Dr. Richard Isaacson founded the Alzheimer’s Prevention Clinic at the NewYork-Presbyterian/Weill Cornell Medical Center, where he’s leading a study examining Alzheimer’s in women, seeking brain changes that occur long before symptoms do. He is joined by UsAgainstAlzheimer's board member Karen Segal, who is participating in this study.Support the show (https://www.usagainstalzheimers.org/ways-donate)

Are we betting on Bitcoin? Or Legos? Plus, the latest investments by Gates Foundation in Alzheimers Research, how NYT journalists cracked open the sexual harassment cases of Bill O'Reilly and Harvey Weinstein, Olympians testing whether the color of their uniforms makes a difference and Lian's reflections on her son's college graduation later this week. Queso or no queso? This week's sponsors are Away (promo code sisters20), RXBars (promo code sisters) Care.com (promo code sisters) and MeUndies (promo code sisters).To visit our online shop, go here. To subscribe to Satellite Sisters on Apple Podcasts, click here. To subscribe to Satellite Sisters on Stitcher, click here.To find Satellite Sisters on Spotify, click here. The complete Satellite Sisters podcast audio archive is here. Don't forget to subscribe to Satellite Sisters Talk TV if you want to listen to Lian and Julie's TV recaps of CBS drama Madam Secretary and PBS Poldark recap Pol,Dark and Handsome. The Satellite Sisters have also announced the return of Satellite Sisters Book Club - monthly interviews featuring biographies, autobiographies and memoirs by and about women. In January, we will be joined by Tina Brown to talk about her juicy new memoir The Vanity Fair Diaries 1983 - 1992. In February, attention all Little House on the Prairie fans! Caroline Fraser is the author of the first comprehensive historical biography of Laura Ingalls Wilder. Prairie Fires: The American Dreams of Laura Ingalls Wilder has been named by the New York Times as one of the 10 best books of 2017. We will let you know exact dates of these episodes soon, but get started reading over the holidays!

Dr Dale Bredesen is an internationally recognized researcher in Alzheimer's.  His incredible resume includes being the Director of the Easton Center for Alzheimer's Research at UCLA as well as founding president and CEO of the Buck Institute on Aging in Novato, California.  He has worked in the lab of 2 nobel prize winners and has run his own labs for 28 years looking at neurodegenerative diseases - focusing on Alzheimer's.   Dr Bredesen's fundamental theory is that Alzheimer's is actually a protective brain response to different classes of insults.   Classes of Insults Leading to Alzheimer’s Inflammation and the brain’s response to pathogens/infections – these trigger the creation of amyloid beta, a key chemical in the brain that destroys brain cell connections and is believed to be a key factor in the development of Alzheimer’s. Amyloid Beta is a part of the Innate Immune system which seems to be over stimulated or dysregulated in most cases of Alzheimer’s. Dr. Bredesen explains the connection of immune activation in Alzheimer’s. Inadequate amounts OR withdrawal of support of brain-“growing” chemicals like B12, vitamin D, and other hormones. This results in a downsizing of the networks of brain cell connections. Sugar toxicity – damages via: advanced glycation end products (AGEs) acting to damage through inflammation as well as, loss of cell supports because of shoddy insulin signaling necessary for healthy brain activity. A protective response by amyloid that bind to things that the brain perceives as a toxin – things like: copper, iron, mercury, biotoxins, infections. People in their 50s and early 60s tend to have the more “toxic” form. Problems with blood vessels and leakiness in the protective blood-brain-barrier which result in lower support chemicals and toxicity. Trauma, e.g., from things like concussions – which also lower chemical and hormone support as well as make the brain susceptible to all the insults mentioned above. The story of “Patient Zero” (Minute 28:53) Dr. Bredesen describes the first success he had with his program. Things that induce Alzheimer’s a.k.a. “Dementogens” Biotoxins Exposures to water building and the harmful effects of mold Tick exposures Heavy Metals Exposure Aluminum, copper, mercury Water damaged building, mycotoxins Certain types of infections Concussions The effects of diabetes and poor diet Certain types of pollution Not enough time asleep or insufficient oxygen when you sleep. Not enough exercise Elements of a “Cognoscopy”Because the brain changes in Alzheimer’s can creep in 20 years or more before symptoms start prevention makes a whole lot of sense. Though a cognoscopy doesn’t really exist yet in a conventional medical setting, Dr. Bredesen’s thinks that one should probably be done around age 45 to assess the risk of developing Alzheimer’s and might include the following: Genetic markers and blood work that elucidates Dr. Bredesen’s three metabolic subtypes (see an MPICognitions.com to find a doctor trained in the protocol). Functional cognitive testing using BrainHQ, Lumosity, Cog-state, CNS vital signs to see where your brain function is in a “testing environment”. Brain MRI with volumetrics (listen to Evolving Past Alzheimer’s podcast with Dr. Cyrus Raji episode #6 for full explanation) if someone has symptoms. The Role of Sleep in Alzheimer’s Time of repair (don’t eat 3 hours before bed) Time for autophagy (brain cell “pruning”) There is a slight change in the microanatomy of the brain where some of the accumulated toxicants get “washed away” Sleep hygiene is important Who typically improves with the Bredesen Program?Dr. Bredesen mentions the “MoCA” which refers to the Montreal Cognitive Assessment. This is a screening test that won’t tell you if someone has Alzheimer’s but can give you a general indication of different levels of cognitive impairment.  Dr. Bredesen mentioned that people that score 22 or greater (out of 30) are seeing improvements with his methodology.  These are people that are typically early on in their disease. Who typically does not improve with the Bredesen Program? People that are more “frail” (less able to exercise, etc.) People that are further along with the disease and have had symptoms for longer periods of time. How much improvement do people see with the Bredesen Program?Some people seem to get just a bit better in terms of mood, outlook, and brain function. Others get much better and almost completely back to their best brain function. Too early to say how many, but more than half of the people using the methodology report some sort of improvement. A discussion of an upcoming Documentary of the impact on people’s lives using Dr. Bredesen’s program.   Resources Dr. Brdesen’s Book: The End of Alzheimer’s To find a Bredesen trained physician, visit Dr. Bredesen’s website – MPI Cognition Website: Institute for Functional Medicine

New research has identified nine primary causes of dementia and Alzheimers in later age, giving us a much better idea about how to prevent the disease, the FT's Clive Cookson tells Andrew Jack See acast.com/privacy for privacy and opt-out information.

Dr. Laurie Ryan was our guest for the June Alzheimer’s Talks presented by UsAgainstAlzheimer's. Dr. Ryan is Chief of the Dementias of Aging Branch in the Division of Neuroscience at the National Institute on Aging, which is part of the National Institutes of Health (NIH). At the National Institute on Aging, she directs Alzheimer’s disease clinical trials research. Dr. Ryan discussed efforts and plans to improve the pace and quality of clinical trials and clinical research, with an emphasis on better strategies for recruiting volunteers into trials. The NIA currently has 59 ongoing clinical trials, many in early-stage clinical drug development, as well as a number of trials looking at non-pharmacological or lifestyle interventions.Support the show (https://www.usagainstalzheimers.org/ways-donate)

For the first Alzheimer’s Talks of 2017 presented by UsAgainstAlzheimer's, we were joined by Dr. Scott Turner of Georgetown University to discuss a fascinating new clinical trial that repurposes an existing cancer drug.Support the show (https://www.usagainstalzheimers.org/ways-donate)

Alzheimers disease is now the leading cause of death in the UK, but there are as yet no treatments to halt or reverse it. There was huge disappointment last week when the drug company Eli Lilly announced that a large, phase 3 clinical trial had failed to show any benefit to mild dementia sufferers from its antibody therapy, solanezumab. So where does this leave our basic understanding of biology of Alzheimers disease and how we might most effectively treat or cure it? Adam Rutherford talks to Alzheimers researcher Tara Spires-Jones of the University of Edinburgh. Also in the programme: The skeleton of the world's most famous fossil, Lucy, has received a body scan which revealed she spent a considerable portion of her life climbing trees. Researchers at the University of Bath are making smart bandages for burns patients which glow when their wounds become infected. Adam also talks to the astrophysicist who gave up studying exploding stars to apply his maths to Hollywood stars in the movie business.

For this Alzheimer’s Talks presented by UsAgainstAlzheimer's, we were honored to have Dr. Rudy Tanzi share with us his fascinating new work on a microbial hypothesis of the causes of Alzheimer’s disease. Dr. Tanzi is the Vice Chair of Neurology and Director of the Genetics and Aging Research Unit at Massachusetts General Hospital and a Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard Medical School. He was chosen by the Geoffrey Beene Foundation as a ‘Rock Star of Science’ and is a Founding Member of our ResearchersAgainstAlzheimer’s network. Support the show (https://www.usagainstalzheimers.org/ways-donate)

Host: Brian P. McDonough, MD, FAAFP Alzheimer’s Disease is the most common cause of dementia among people aged 65 and older. With the population of older Americans growing, research for new therapies becomes ever more critical. Yet one of the most important factors in advancing research, fundraising, has been hampered by numerous challenges. Host Dr. Brian McDonough talks with Charles Fushcillo Jr., President and Chief Executive Officer of the Alzheimer’s Foundation of America about the challenges in securing additional funding for Alzheimer’s Research.

Host: Brian P. McDonough, MD, FAAFP Alzheimer’s Disease is the most common cause of dementia among people aged 65 and older. With the population of older Americans growing, research for new therapies becomes ever more critical. Yet one of the most important factors in advancing research, fundraising, has been hampered by numerous challenges. Host Dr. Brian McDonough talks with Charles Fushcillo Jr., President and Chief Executive Officer of the Alzheimer’s Foundation of America about the challenges in securing additional funding for Alzheimer’s Research.

In USAgainstAlzheimer's July Alzheimer’s Talks, Dr. Michael Rafii – Medical Director of the Alzheimer’s Disease Cooperative Study (ADCS), Director of the Memory Disorders Clinic and Assistant Professor of Neurosciences at the University of California, San Diego and Attending Neurologist at the Shiley-Marcos Alzheimer’s Disease Research Center – joined us to discuss his exciting work on the NOBLE and A4 studies, coordinated by the ADCS. With new imaging technology and a greater understanding of the progression of Alzheimer’s guiding clinical trials, there’s hope on the horizon for Alzheimer’s treatment and prevention.Support the show (https://www.usagainstalzheimers.org/ways-donate)

Genetic modification, Black Salve, pregnancy, and paracetamol. Plus cancer roots, bicarbonate of soda, designer babies, and ‘scientists.’ Only painful after the procedure, it’s Skeptics with a K. Donate to the Merseyside Skeptics Charity Walk for Alzheimers Research at: Just Giving.

1) Age of first exposure to football and the effect of later-life cognitive impairment on former NFL players and 2) Topic of the month: Stroke in systemic disease. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Howard Goodkin interviews Dr. Robert Stern about his paper on the age of first exposure to football and the effect of later-life cognitive impairment on former NFL players. Dr. James Addington is reading our e-Pearl of the week about REM behavior disorder. In the next part of the podcast Dr. Michelle Johansen interviews Dr. Kevin Barrett about the topic of stroke in the setting of Endocrine disorders. The participants had nothing to disclose except Drs. Goodkin, Stern, Addington, Johansen and Barrett.Dr. Goodkin serves on the scientific advisory board for Tuberous Sclerosis Alliance and CURE Infantile Spasms; serves as an editorial board member of Neurology, Surgical Neurology International and Epilepsia; receive a royalty from UpToDate for co-authorship of an entry entitled The "choking game" and other strangulation activities in children and adolescents; will be receiving royalties for editing Epilepsy as part of the Neurology in Practice series and receives research support from the NIH.Dr. Stern serves as an Associate Editor of Journal of Neuropsychiatry and Clinical Neurosciences; serves as an editorial board member of Archives of Clinical Neuropsychology; serves as a Review Editor of Frontiers in Neurotrauma and Frontiers in Sports Neurology; serves as Series Editor of Alzheimer's Research and Therapy; serves on the Mackey-White Traumatic Brain Injury Committee of the National Football League Players Association; serves on the medical advisory board of Sports Legacy Institute, the National Graves' Disease Foundation and Amarantus Biosciences (paid advisor); serves on the Medical and Scientific Advisory Committee of the MA/NH Chapter of the Alzheimer's Association; is a consultant for Janssen Research & Development and Athena Diagnostics; receives publishing royalties from Psychological Assessment Resources, Inc. for the Visual Analog Mood Scales, the Boston Qualitative Scoring System for the Rey-Osterreith Complex Figure, and the Neuropsychological Assessment Battery; receives research support from Eisai Inc., Eli Lilly and Company, Amarantus Biosciences, Aethlon Medical, Avid Radiopharmaceuticals, the Department of Defense and the NIH; received honorariums from, Braintree Neurorehabilitation Conference, National Academy of Neuropsychology, Harvard Medical School, The German Center for Research and Innovation and Ludwig-Maximilians-Universitat Munchen, Medical University of South Carolina, Spaulding Rehabilitation Hospital and 8th Annual National Summit on Sports Concussion.Dr. Addington serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Johansen serves as a scientific advisory member of Stroke and as a contributor to Blogging Stroke.Dr. Kevin Barrett serves as an Associate Editor of Neurohospitalist; serves as an editorial board member of Neurology; and receives research support from the NIH.

Jeffrey D. Bernstein is a Researcher in the Stanford Center for Memory Disorders Stanford School of Medicine, Department of Neurology and Neurological Sciences. Jeffrey discusses his work with volunteers and patients in current studies. For more info, go to www.neurology.stanford.edu/labs/kerchnerlab

Jeffrey D. Bernstein is a Researcher in the Stanford Center for Memory Disorders Stanford School of Medicine, Department of Neurology and Neurological Sciences. Jeffrey discusses his work with volunteers and patients in current studies. For more info, go to www.neurology.stanford.edu/labs/kerchnerlab

Today Paul Pepper visits with BRIAN and AMELIA COTTLE , advocates for Alzheimer's research after Brian was diagnosed with the disease at just 53 years-old. August 7, 2014

Dr. Sperling is leading a groundbreaking new study on individuals whose brain scans show plaque buildups but do not yet demonstrate clinical symptoms of Alzheimer’s or other dementias. She will be testing the effectiveness of the Eli Lilly drug solanezumab, which in previous studies has shown might have promise with people that have a milder form of Alzheimer’s.Dr. Sperling is the Director of the Center for Alzheimer's Research and Treatment, the Director of the Education and Information Transfer Core, Massachusetts Alzheimer's Disease Research Center, Co-Leader of the Neuroimaging Program, Massachusetts Alzheimer's Disease Research Center, and a Professor of Neurology at Harvard Medical SchoolThis call was made possible by the generous support of Jill Lesser, Board member of USAgainstAlzheimer's Network. Support the show (https://www.usagainstalzheimers.org/ways-donate)

An interview with historian Professor Virginia Scharff who recently wrote The Women Jefferson Loved. Throughout his life, Thomas Jefferson constructed a seemingly impenetrable wall between his public legacy and his private life. Dr. Eva Chi shares her groundbreaking research into finding a cure for Alzheimers as she seeks answers for what causes proteins to go bad in the brain. Recipient of President Obama's Early Career Award for Scientists and Engineers, Dr. Yasamin Mostofi looks to future and answers the question of how we get robots to think for themselves. Produced by New Mexico PBS, CONNECT shares the inspired thinking and innovative research of the University of New Mexico. The Producer of CONNECT is Brad Stoddard. The Executive Producer is Michael Kamins. Production support provided by the University of New Mexico. www.newmexicopbs.org

Alzheimer's Research & the Possibilities Today I will interview H. Rock Liao,Ph.D who is one of the Harvard Neurobogiologists who recently founded a company focusing on developing anti-Alzheimer's drugs using a proprietary drug-screening system based on real brain cells. Here is their contact information Neurox Pharmaceuticals, Inc. Woburn, MA 01801 Email: info@neurox.us Fax: 801-659-8468 http://www.neurox.us/Support this Show: https://alzheimersspeaks.com/donate-now/See omnystudio.com/listener for privacy information.

The 1st half of the show we will be talking with William H. Frey II, Ph.D., Director Alzheimer's Research Center and Professor of Pharmaceutics, Neurology  and Neuroscience University of Minnesota about: What is Alzheimer's disease?  Why has it taken so long to find effective ways to treat and prevent Alzheimer's disease?  Intranasal insulin treatment and Stem cells Research and Dementia Contact Information- Alzheimer's Research Center 800-229-2872 Website: www.alzheimersinfo.org   The 2nd half of the show we will be talking with David Adelman is the Founder and CEO of Reel Tributes, and Claire Day, Vice President Constituent Services Alzheimer's Association Delaware Valley Chapter regarding “YOUR FAVORITE MEMORY CONTEST” The contest is being organized by the Alzheimer's Association Delaware Valley Chapter and Reel Tributes (www.reeltributes.com) This innovative contest will encourage families to write a short story about a memorable experience with their family member suffering from Alzheimer's disease. The website is www.reeltributes.com/memory. The contest video can be found at http://youtu.be/95TUvUV6x2g Contact info: Adelman@reeltributes.com www.reeltributes.com/memorySupport this Show: https://alzheimersspeaks.com/donate-now/See omnystudio.com/listener for privacy information.